[Prevention of thromboembolic disease in gynecology and obstetrics. Trial of tanderil].
D000074:Acenocoumarol / Q000008:administration & dosage; D002585:Cesarean Section; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery*; D006801:Humans; D007866:Leg / Q000098:blood supply; D007744:Obstetric Labor Complications / Q000517:prevention & control*; D010113:Oxyphenbutazone / Q000008:administration & dosage*; D010689:Phlebitis / Q000150:complications; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011655:Pulmonary Embolism; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control
D003911:Dextrans; D010113:Oxyphenbutazone; D000074:Acenocoumarol
Prophylaxie de la maladie thrombo-embolique engynécologie-obstétrique. Essai du Tandéril.